Dermatological Manifestations of Glucagon‐Like Peptide‐1 Receptor Agonists
ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‑1 RAs) play a pivotal role in treating type 2 diabetes. Despite their widespread use, their dermatological manifestations remain under‐recognized, hence the interest of this systematic review. Objectives This systematic review aims t...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2026-06-01
|
| Serija: | JEADV Clinical Practice |
| Teme: | |
| Online dostop: | https://doi.org/10.1002/jvc2.70266 |
| Oznake: |
Brez oznak, prvi označite!
|